Alnylam Pharmaceuticals Company Profile News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alnylam pharmaceuticals company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alnylam Pharmaceuticals Company Profile Today - Breaking & Trending Today

Insider Selling: Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Director Sells 21,700 Shares of Stock

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) Director Amy W. Schulman sold 21,700 shares of Alnylam Pharmaceuticals stock in a transaction on Wednesday, May 29th. The stock was sold at an average price of $148.60, for a total value of $3,224,620.00. Following the transaction, the director now directly owns 8,436 shares of the company’s […] ....

Amyw Schulman , Securities Exchange Commission , Allspring Global Investments Holdings , Altitude Crest Partners Inc , Alnylam Pharmaceuticals Stock Down , Alnylam Pharmaceuticals Inc , Quent Capital , Investment Management , Wells Fargo Company , Morgan Stanley , News Ratings For Alnylam Pharmaceuticals Daily , Alnylam Pharmaceuticals Company Profile , Alnylam Pharmaceuticals , Get Free Report , Director Amy , Exchange Commission , Pharmaceuticals Stock Down , Global Investments Holdings , Crest Partners , Alnylam Pharmaceuticals Daily ,

Alnylam Pharmaceuticals (NASDAQ:ALNY) Releases Quarterly Earnings Results, Beats Expectations By $0.23 EPS

Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) posted its earnings results on Thursday. The biopharmaceutical company reported ($0.52) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.75) by $0.23, Briefing.com reports. The firm had revenue of $494.33 million for the quarter, compared to analyst estimates of $428.01 million. During the same […] ....

William Blair , Cantor Fitzgerald , News Ratings For Alnylam Pharmaceuticals Daily , Alnylam Pharmaceuticals Company Profile , Earnings History For Alnylam Pharmaceuticals , Jpmorgan Chase Co , Alnylam Pharmaceuticals Inc , Alnylam Pharmaceuticals , Alnylam Pharmaceuticals Stock , Goldman Sachs Group , Get Free Report , Alnylam Pharmaceuticals Daily , Nasdaq Alny ,